Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies-Reference-Cited by-同舟云学术

Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies

Published:2013-04 Issue:4 Volume:73 Page:449-458
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Piazza Fabrizio¹,Greenberg Steven M.²,Savoiardo Mario³,Gardinetti Margherita¹,Chiapparini Luisa³,Raicher Irina⁴,Nitrini Ricardo⁴,Sakaguchi Hideya⁵,Brioschi Monica⁶,Billo Giuseppe⁷,Colombo Antonio⁸,Lanzani Francesca⁸,Piscosquito Giuseppe⁹,Carriero Maria Rita⁹,Giaccone Giorgio¹⁰,Tagliavini Fabrizio¹⁰,Ferrarese Carlo¹,DiFrancesco Jacopo C.¹

Affiliation:

1. Department of Neuroscience and Biomedical Technologies; University of Milano-Bicocca; Monza; Italy

2. Hemorrhagic Stroke Research Program, Department of Neurology; Massachusetts General Hospital, Harvard Medical School; Boston; MA

3. Department of Neuroradiology; IRCCS Foundation Neurological Institute Carlo Besta,; Milan; Italy

4. Department of Neurology; University of São Paulo School of Medicine; São Paulo; Brazil

5. Department of Neurology; Graduate School of Medical Sciences, Kumamoto University; Kumamoto; Japan

6. Department of Neurosciences; Niguarda Ca' Granda Hospital; Milan; Italy

7. Department of Neurology; St. Bortolo Hospital; Vicenza; Italy

8. Department of Neurology; Desio Hospital; Desio; Italy

9. Department of Cerebrovascular Diseases; IRCCS Foundation Neurological Institute Carlo Besta,; Milan; Italy

10. Department of Neurodegenerative Diseases and Division of Neuropathology-Neurology; IRCCS Foundation Neurological Institute Carlo Besta,; Milan; Italy

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference38 articles.

3. Safety and tolerability of the gamma-Secretase Inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease;Coric;Arch Neurol,2012

4. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab;Ostrowitzki;Arch Neurol,2012

5. Immunotherapy reduces vascular amyloid-beta in PDAPP mice;Schroeter;J Neurosci,2008

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging of Amyloid-beta-related Arteritis;Neuroimaging Clinics of North America;2024-02

2. Fluid biomarkers in cerebral amyloid angiopathy;Frontiers in Neuroscience;2024-01-26

3. Inflammatory cerebral amyloid angiopathy with poor outcome – case report;Aktualności Neurologiczne;2023-11-30

4. Case report: Cerebral amyloid angiopathy-related inflammation in a patient with granulomatosis with polyangiitis;Frontiers in Neurology;2023-11-09

5. Advancing Alzheimer’s care: a novel therapy with lecanemab;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2023-11-02